NCT00333918View on ClinicalTrials.gov

Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

522

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
PainInflammation
Interventions
DRUG

bromfenac ophthalmic solution

DRUG

placebo comparator

Trial Locations (1)

92618

Irvine

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00333918 - Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery | Biotech Hunter | Biotech Hunter